NASDAQ:STLN | EBITDA Margin | Starling Oncology, Inc.

Complete source-backed ebitda margin history.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2026-03-31-3.32%
2025-12-31-3.72%
2025-03-31-7.78%
2024-12-31-10.19%
2024-03-31-17.41%
2023-12-31-15.98%
2023-03-31-41.47%
2022-12-31-33.44%
2022-03-31-31.70%
2021-12-31-76.31%
2021-03-31-2.01%

Annual EBITDA Margin

DateEBITDA Margin
2025-12-31-5.80%
2024-12-31-13.68%
2023-12-31-21.94%
2022-12-31-30.71%
2021-12-31-20.94%
2020-12-31-2.68%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.